DIALYSIS 452706
A dialysis facility in TX. It ran an operating surplus of 9.3% in FY23 on $2.5M of operating revenue.
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gatedRatios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio computes only when every input is reported in the filing (otherwise its cell states which input is Not reported in source); a year whose balance sheet does not reconcile is labeled, and its derived ratios read Astrelis calculation unavailable. Not audited by Astrelis.
| Line item | FY20 | FY21 | FY23 |
|---|---|---|---|
| Patient revenue | 2,583 | 2,436 | 2,490 |
| Total operating revenue | 2,583 | 2,436 | 2,490 |
| Total operating expenses | 2,354 | 2,338 | 2,258 |
| Operating income | 229 | 98 | 232 |
| Operating margin % | +8.9% | +4.0% | +9.3% |
| Other non-operating, net | 0 | 0 | 5 |
| Net income | 229 | 98 | 237 |
| Net income % | +8.9% | +4.0% | +9.5% |
How it operates
quality & operational context · CMS public reportingThe metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by provenance class and public source; descriptive context only, never a ranking or adequacy claim. Provenance labels: Reported value is copied from the named public source; Astrelis calculation is a formula applied to unchanged reported inputs, with the formula shown; Illustrative estimate is a benchmark gap, multiplier, or scenario — never a measurement.
Trajectory
State context
9.3% operating margin in FY23.
What changed, what matters, and what your board should ask — every figure sourced to the public record.
Reserve The Board Briefing →The Board Briefing
The record's final filed years, benchmarked against the peer pools of their own era and labeled so on every exhibit.